These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. KIT pathway alterations in mucosal melanomas of the vulva and other sites. Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547 [TBL] [Abstract][Full Text] [Related]
3. KIT amplification and gene mutations in acral/mucosal melanoma in Korea. Yun J; Lee J; Jang J; Lee EJ; Jang KT; Kim JH; Kim KM APMIS; 2011 Jun; 119(6):330-5. PubMed ID: 21569090 [TBL] [Abstract][Full Text] [Related]
4. KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases. Zebary A; Jangard M; Omholt K; Ragnarsson-Olding B; Hansson J Br J Cancer; 2013 Aug; 109(3):559-64. PubMed ID: 23860532 [TBL] [Abstract][Full Text] [Related]
5. Genetic aberrations in primary esophageal melanomas: molecular analysis of c-KIT, PDGFR, KRAS, NRAS and BRAF in a series of 10 cases. Langer R; Becker K; Feith M; Friess H; Höfler H; Keller G Mod Pathol; 2011 Apr; 24(4):495-501. PubMed ID: 21131919 [TBL] [Abstract][Full Text] [Related]
6. BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs. Wong CW; Fan YS; Chan TL; Chan AS; Ho LC; Ma TK; Yuen ST; Leung SY; J Clin Pathol; 2005 Jun; 58(6):640-4. PubMed ID: 15917418 [TBL] [Abstract][Full Text] [Related]
7. GAB2 amplifications refine molecular classification of melanoma. Chernoff KA; Bordone L; Horst B; Simon K; Twadell W; Lee K; Cohen JA; Wang S; Silvers DN; Brunner G; Celebi JT Clin Cancer Res; 2009 Jul; 15(13):4288-91. PubMed ID: 19509136 [TBL] [Abstract][Full Text] [Related]
8. [ Spectrum of oncogene mutations is different in melanoma subtypes]. Mazurenko NN; Tsyganova IV; Lushnikova AA; Ponkratova DA; Anurova OA; Cheremushkin EA; Mikhailova IN; Demidov LV Mol Biol (Mosk); 2015; 49(6):1022-9. PubMed ID: 26710785 [TBL] [Abstract][Full Text] [Related]
9. SF3B1, NRAS, KIT, and BRAF Mutation; CD117 and cMYC Expression; and Tumoral Pigmentation in Sinonasal Melanomas: An Analysis With Newly Found Molecular Alterations and Some Population-Based Molecular Differences. Wroblewska JP; Mull J; Wu CL; Fujimoto M; Ogawa T; Marszalek A; Hoang MP Am J Surg Pathol; 2019 Feb; 43(2):168-177. PubMed ID: 30273197 [TBL] [Abstract][Full Text] [Related]
10. KIT Suppresses BRAF Neiswender JV; Kortum RL; Bourque C; Kasheta M; Zon LI; Morrison DK; Ceol CJ Cancer Res; 2017 Nov; 77(21):5820-5830. PubMed ID: 28947418 [TBL] [Abstract][Full Text] [Related]
11. KIT gene mutations and copy number in melanoma subtypes. Beadling C; Jacobson-Dunlop E; Hodi FS; Le C; Warrick A; Patterson J; Town A; Harlow A; Cruz F; Azar S; Rubin BP; Muller S; West R; Heinrich MC; Corless CL Clin Cancer Res; 2008 Nov; 14(21):6821-8. PubMed ID: 18980976 [TBL] [Abstract][Full Text] [Related]
12. Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma. Hou JY; Baptiste C; Hombalegowda RB; Tergas AI; Feldman R; Jones NL; Chatterjee-Paer S; Bus-Kwolfski A; Wright JD; Burke WM Cancer; 2017 Apr; 123(8):1333-1344. PubMed ID: 28026870 [TBL] [Abstract][Full Text] [Related]
13. Oncogene abnormalities in a series of primary melanomas of the sinonasal tract: NRAS mutations and cyclin D1 amplification are more frequent than KIT or BRAF mutations. Chraybi M; Abd Alsamad I; Copie-Bergman C; Baia M; André J; Dumaz N; Ortonne N Hum Pathol; 2013 Sep; 44(9):1902-11. PubMed ID: 23664541 [TBL] [Abstract][Full Text] [Related]
15. NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract--a study of 24 cases from the Netherlands. van Engen-van Grunsven AC; Küsters-Vandevelde HV; De Hullu J; van Duijn LM; Rijntjes J; Bovée JV; Groenen PJ; Blokx WA Gynecol Oncol; 2014 Jul; 134(1):10-4. PubMed ID: 24802725 [TBL] [Abstract][Full Text] [Related]
16. Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas. Griewank KG; Westekemper H; Murali R; Mach M; Schilling B; Wiesner T; Schimming T; Livingstone E; Sucker A; Grabellus F; Metz C; Süsskind D; Hillen U; Speicher MR; Woodman SE; Steuhl KP; Schadendorf D Clin Cancer Res; 2013 Jun; 19(12):3143-52. PubMed ID: 23633454 [TBL] [Abstract][Full Text] [Related]
17. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases. Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561 [TBL] [Abstract][Full Text] [Related]
18. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases. Öztürk Sari Ş; Yilmaz İ; Taşkin OÇ; Narli G; Şen F; Çomoğlu Ş; Firat P; Bİlgİç B; Yilmazbayhan D; Özlük Y; Büyükbabanİ N Pathology; 2017 Jan; 49(1):55-61. PubMed ID: 27914687 [TBL] [Abstract][Full Text] [Related]
19. Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract. Cai YJ; Ke LF; Zhang WW; Lu JP; Chen YP BMC Cancer; 2021 Jun; 21(1):677. PubMed ID: 34102999 [TBL] [Abstract][Full Text] [Related]
20. KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma. Zebary A; Omholt K; Vassilaki I; Höiom V; Lindén D; Viberg L; Kanter-Lewensohn L; Johansson CH; Hansson J J Dermatol Sci; 2013 Dec; 72(3):284-9. PubMed ID: 23993026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]